The Globe and Mail reports in its Friday, May 8, edition that TD Cowen analyst Mario Mendonca is keeping his "buy" recommendation for Great-West Lifeco intact. The Globe's David Leeder writes in the Eye On Equities column that Mr. Mendonca gave his share target a $7 boost to $80. Analysts on average target the shares at $72. Mr. Mendonca says in a note: "We characterize Great-West Lifeco's Q1/26 results as the strongest among the large insurers so far. Solid growth in the U.S. retirement and wealth earnings (margins) and better flows in retirement (slightly softer net flows in wealth), accelerating growth in capital solutions and a nearly 20-per-cent ROE in the quarter support this characterization. Buyback activity has continued at a strong pace into 2026." The Globe reported on Feb. 7, 2025, and April 4, 2025, that Mr. Mendonca rated Great-West Lifeco "buy." The shares could then be had for $52.39 and $56.77. The Globe reported on April 24, 2026, that National Bank analyst Gabriel Dechaine continued to rate Great-West Lifeco "sector perform." The shares were then worth $71.32.